Data as of Dec 12
| +0.21 / +1.47%|
The 8 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 16.50, with a high estimate of 18.00 and a low estimate of 10.00. The median estimate represents a +13.79% increase from the last price of 14.50.
The current consensus among 9 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.